Results 131 to 140 of about 13,147 (200)

Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design. [PDF]

JACS Au
Wen Y, Wu YH, Sun QN, Wang EY, Luo MQ, Fu ZR, Zhou Z, Mei DX, Guo J.   +8 more
europepmc   +1 more source

Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances. [PDF]

Int J Mol Sci
Aloliqi AA, Alnuqaydan AM, Alshebremi M, Khan A, Khan MA.   +4 more
europepmc   +1 more source

Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia. [PDF]

Leukemia
Li YR, Shen X, Chen Y, Zhu Y, Huang J, Oliai C, Yang L.   +6 more
europepmc   +1 more source

FOXP3-activated KCNMB2-AS1 promotes clear cell renal cell carcinoma through the miR-744-3p/CD1D axis. [PDF]

Cell Div
Huang G, Gui D, Guo Y, Luo S, Xu Z.
europepmc   +1 more source

Antigen-Presenting Glycoprotein CD1d [PDF]

, 2020
openaire   +1 more source

Detergents alter the stability and lipid binding properties of the CD1d immunoreceptor. [PDF]

Protein Sci
Miles UZ, Finn MG, McShan AC.
europepmc   +1 more source

Invariant and Diverse NKT Cells Regulate Bacterial Clearance and Pathology in Chlamydial Genital Tract Infection in Mice. [PDF]

Pathogens
Ishii K, Soejima T, Ohnishi Y, Ozuru R, Itoh R, Chou B, Yoshimura M, Shimizu A, Kurihara Y, Sakamoto A, Hiromatsu K.   +10 more
europepmc   +1 more source

Role of Donor Unrestricted T Cells (DURTs) in TB Host Defense: Implications for Novel TB Vaccine Development. [PDF]

Vaccines (Basel)
Kain D, Lewinsohn DM, Lewinsohn DA.
europepmc   +1 more source

Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells. [PDF]

Clin Cancer Res
Courtney AN, Zhou X, Tian G, Wang Y, Metelitsa LS, Dotti G.   +5 more
europepmc   +1 more source

Dysregulated B cell homeostasis and the involvement of B cell-activating factor in the progression of diabetic retinopathy. [PDF]

Sci Rep
Wang Y, Cui L, He W, Zhou Y, Zhao Z, Lu H, Ke D, Wu Q, Deng W, Zhou Z, Xu F, Zhong H, Tang F.   +12 more
europepmc   +1 more source